Natalie Danziger

1.2k total citations
86 papers, 579 citations indexed

About

Natalie Danziger is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Natalie Danziger has authored 86 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cancer Research, 32 papers in Oncology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Natalie Danziger's work include Cancer Genomics and Diagnostics (35 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Natalie Danziger is often cited by papers focused on Cancer Genomics and Diagnostics (35 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Natalie Danziger collaborates with scholars based in United States, Italy and United Kingdom. Natalie Danziger's co-authors include Jeffrey S. Ross, Richard S.P. Huang, Shakti Ramkissoon, Douglas I. Lin, Julia A. Elvin, Priti S. Hegde, Brian M. Alexander, Dean C. Pavlick, Kimberly McGregor and Kim Blenman and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Natalie Danziger

77 papers receiving 573 citations

Peers

Natalie Danziger
Anna Felisiak-Gołąbek Poland
Eriko Aimono Japan
Kanae Nosaka Japan
J.M. del Campo Spain
Amanda Hemmerich United States
Rita Abi‐Raad United States
Yufeng Luo China
Ha Young Woo South Korea
Giovana Tardin Torrezan Brazil
James Sun United States
Anna Felisiak-Gołąbek Poland
Natalie Danziger
Citations per year, relative to Natalie Danziger Natalie Danziger (= 1×) peers Anna Felisiak-Gołąbek

Countries citing papers authored by Natalie Danziger

Since Specialization
Citations

This map shows the geographic impact of Natalie Danziger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Danziger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Danziger more than expected).

Fields of papers citing papers by Natalie Danziger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Danziger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Danziger. The network helps show where Natalie Danziger may publish in the future.

Co-authorship network of co-authors of Natalie Danziger

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Danziger. A scholar is included among the top collaborators of Natalie Danziger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Danziger. Natalie Danziger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Slomovitz, Brian M., Natalie Danziger, Júlia C.F. Quintanilha, et al.. (2025). Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer. International Journal of Gynecological Cancer. 35(10). 102107–102107. 1 indexed citations
2.
Byrne, C, Natalie Danziger, Jeffrey S. Ross, et al.. (2025). 776 POLE-Ultramutated Prostatic Carcinoma: a Rare Molecularly Defined Prostate Cancer Subtype With Potential for Durable Response to Immunotherapy. Laboratory Investigation. 105(3). 103009–103009.
3.
Richardson, Debra L., Júlia C.F. Quintanilha, Natalie Danziger, et al.. (2024). Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice. Clinical Cancer Research. 30(20). 4644–4653. 5 indexed citations
4.
Rosenberger, Laura H., Richard F. Riedel, Emilia J. Diego, et al.. (2024). Genomic landscape of malignant phyllodes tumors reveals multiple targetable opportunities. The Oncologist. 29(12). 1024–1031. 9 indexed citations
5.
Clark, Allison, Mehrad Tavallai, Dexter X. Jin, et al.. (2024). Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes. Breast Cancer Research. 26(1). 118–118. 2 indexed citations
6.
Posada, Jessica M., Evgeny Yakirevich, Ashish M. Kamat, et al.. (2024). Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2. Modern Pathology. 37(3). 100424–100424. 8 indexed citations
7.
Pothuri, Bhavana, et al.. (2024). 735P HRD signature (HRDsig) in endometrial cancer (EC). Annals of Oncology. 35. S559–S559. 1 indexed citations
8.
Lin, Douglas I., Júlia C.F. Quintanilha, Natalie Danziger, et al.. (2024). Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab. npj Precision Oncology. 8(1). 204–204. 6 indexed citations
9.
Parimi, Vamsi, Khaled Tolba, Natalie Danziger, et al.. (2023). Genomic landscape of 891 RET fusions detected across diverse solid tumor types. npj Precision Oncology. 7(1). 10–10. 34 indexed citations
10.
Peak, Taylor, Philippe E. Spiess, Roger Li, et al.. (2023). Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry. The Oncologist. 28(10). e910–e920. 1 indexed citations
11.
Kumar, Prashanth Ashok, Serenella Serinelli, Richard S.P. Huang, et al.. (2023). Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma. Frontiers in Oncology. 13. 1169586–1169586. 6 indexed citations
12.
Spiess, Philippe E., Roger Li, Petros Grivas, et al.. (2023). Penile squamous cell carcinoma (PSCC) with elevated tumor mutational burden (TMB): A genomic landscape study.. Journal of Clinical Oncology. 41(6_suppl). 4–4. 1 indexed citations
13.
14.
Zerdan, Maroun Bou, Joseph M Jacob, Philippe E. Spiess, et al.. (2023). HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study. Urologic Oncology Seminars and Original Investigations. 41(12). 486.e15–486.e23. 3 indexed citations
15.
Sivakumar, Smruthy, Dexter X. Jin, Hanna Tukachinsky, et al.. (2022). Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer. Nature Communications. 13(1). 7495–7495. 26 indexed citations
16.
Sharaf, Radwa, Dean C. Pavlick, Garrett M. Frampton, et al.. (2021). FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas. Neuro-Oncology Advances. 3(1). vdab017–vdab017. 4 indexed citations
17.
Necchi, Andrea, Petros Grivas, Gennady Bratslavsky, et al.. (2021). 710P Comprehensive genomic profiling (CGP) of small cell neuroendocrine carcinoma of the bladder (NEBC). Annals of Oncology. 32. S718–S718. 1 indexed citations
18.
Huang, Richard S.P., Shoua Yang, Nicholas Britt, et al.. (2020). Correlating ROS1 Protein Expression With ROS1 Fusions, Amplifications, and Mutations. JTO Clinical and Research Reports. 2(2). 100100–100100. 11 indexed citations
19.
Sokol, Ethan S., Natalie Danziger, Dean C. Pavlick, et al.. (2020). 107P Immune Checkpoint Inhibitor (ICPI) resistance genes STK11 and KEAP1: A comparative Comprehensive Genomic Profiling (CGP) study. Annals of Oncology. 31. S283–S284.
20.
Williams, Erik A., Natalie Danziger, Meagan Montesion, et al.. (2020). Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms. Journal of the American Academy of Dermatology. 84(4). 1069–1071. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Felisiak-Gołąbek Breakdown of academic impact, for papers by Eriko Aimono Breakdown of academic impact, for papers by Kanae Nosaka Breakdown of academic impact, for papers by J.M. del Campo Breakdown of academic impact, for papers by Amanda Hemmerich Breakdown of academic impact, for papers by Rita Abi‐Raad Breakdown of academic impact, for papers by Yufeng Luo Breakdown of academic impact, for papers by Ha Young Woo Breakdown of academic impact, for papers by Giovana Tardin Torrezan Breakdown of academic impact, for papers by James Sun
Rankless by CCL
2026